Notably, when cells derived from tumours harvested from MMTV-PyMT.CCR5−/− mice (described in Material and methods) are treated with CCL5, we observe no enhancement in glucose uptake, in support that CCR5 is the receptor mediating this effect (figure 2d). This evidence concerns the gene CCL5 and neoplasm.